Literature DB >> 21658612

Follicular lymphoma grade 3B.

Itziar Salaverria1, Reiner Siebert.   

Abstract

Follicular lymphoma (FL) grade 3B (FL3B) is defined as FL with more than 15% centroblasts per high resolution field present as solid sheets. Coexistence with diffuse large B-cell lymphoma (DLBCL) is frequent. In contrast to other FL, FL3B frequently lack CD10 expression (approximately 50% of cases), show lower probability of BCL2 expression (69% positive) and increased TP53 expression (31% positive). The t(14;18) hallmark translocation of FL is present in only around 13% of FL3B. In contrast, translocations affecting the BCL6 locus in 3q27 are frequent (44%). Overall, FL3B in many features resembles DLBCL. The presence of a diffuse component in FL3B has been related to an unfavorable outcome except for pediatric FL3B that presents in 60% of the cases this DLBCL component. In this chapter we sought to review the present knowledge on morphological, cytogenetic and molecular features in FL3B.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658612     DOI: 10.1016/j.beha.2011.02.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  3 in total

Review 1.  Pathogenesis of follicular lymphoma.

Authors:  Robert Kridel; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

2.  Apoptosis inhibition or inflammation: the role of NAIP protein expression in Hodgkin and non-Hodgkin lymphomas compared to non-neoplastic lymph node.

Authors:  Safoura Mazrouei; Amin Ziaei; Amir Pouya Tanhaee; Kianoosh Keyhanian; Mahdad Esmaeili; Azar Baradaran; Mansoor Salehi
Journal:  J Inflamm (Lond)       Date:  2012-02-23       Impact factor: 4.981

Review 3.  The broad landscape of follicular lymphoma: Part II.

Authors:  Stefano Fratoni; Magda Zanelli; Maurizio Zizzo; Francesca Sanguedolce; Valentina Aimola; Giulia Cerrone; Linda Ricci; Alessandra Filosa; Giovanni Martino; Antonella Maria Fara; Valerio Annessi; Alessandra Soriano; Stefano Ascani
Journal:  Pathologica       Date:  2020-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.